ISSN: 0969-7128

Journal Home

Journal Guideline

Gene Therapy Q2 Unclaimed

Nature Publishing Group United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Gene Therapy is a journal indexed in SJR in Molecular Biology and Genetics with an H index of 164. It has a price of 3690 €. It has an SJR impact factor of 0.927 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0.927.

Gene Therapy focuses its scope in these topics and keywords: gene, expression, transfer, cells, vivo, therapy, rna, dna, cardiac, suicide, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Genetics (Q2) Molecular Biology (Q2) Molecular Medicine (Q2)

Price

3690 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

0.927

SJR Impact factor

164

H Index

122

Total Docs (Last Year)

167

Total Docs (3 years)

6000

Total Refs

682

Total Cites (3 years)

150

Citable Docs (3 years)

3.47

Cites/Doc (2 years)

49.18

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Biochimica et Biophysica Acta - Molecular Cell Research Q2
Molecular and Cellular Neurosciences Q2
Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids Q2
Human Gene Therapy Q2
Progress in Molecular Biology and Translational Science Q2

Compare this journals

Aims and Scope

Best articles by citations

Fas ligand gene-carrying adeno-5 AdEasy viruses can be efficiently propagated in apoptosis-sensitive human embryonic retinoblast 911 cells

Gene transfer of Fc-fusion cytokine by in vivo electroporation: application to gene therapy for viral myocarditis

Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis

In vivo gene delivery into ocular tissues by eye drops of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO) polymeric micelles

Triggered intracellular activation of disulfide crosslinked polyelectrolyte gene delivery complexes with extended systemic circulation in vivo

Particle-mediated gene transfer into murine livers using a newly developed gene gun

Revisiting the mouse lung model for CF

Rapamycin control of exocrine protein levels in saliva after adenoviral vector-mediated gene transfer

Combination of a new generation of PNAs with a peptide-based carrier enables efficient targeting of cell cycle progression

Ex vivo gene therapy in autologous bone marrow stromal stem cells for tissue-engineered maxillofacial bone regeneration

Electrically mediated plasmid DNA delivery to hepatocellular carcinomas in vivo

Prevention of spontaneous neu-expressing mammary tumor development in mice transgenic for rat proto-neu by DNA vaccination

SHOW MORE ARTICLES

Therapeutic effect of DNA vaccines combined with chemotherapy in a latent infection model after aerosol infection of mice with Mycobacterium tuberculosis

Enhanced apoptosis following treatment with TRA-8 anti-human DR5 monoclonal antibody and overexpression of exogenous Bax in human glioma cells

Adenoviral gene transfer into the normal and injured spinal cord: enhanced transgene stability by combined administration of temperature-sensitive virus and transient immune blockade

Direct in vivo transfection of antisense Fas-ligand reduces tumor growth and invasion

Inhibition of human non-small cell lung tumors by a c-Met antisense/U6 expression plasmid strategy

Simultaneous stimulation of Fas-mediated apoptosis and blockade of costimulation prevent autoimmune diabetes in mice induced by multiple low-dose streptozotocin

Enhancement of suicidal DNA vaccine potency by delaying suicidal DNA-induced cell death

Stable polyplexes based on arginine-containing oligopeptides for in vivo gene delivery

Anti-tumor immunity induced by murine melanoma cells transduced with the Mycobacterium tuberculosis gene encoding the 38-kDa antigen

Anti-tumour activity against B16-F10 melanoma with a GM-CSF secreting allogeneic tumour cell vaccine

Tumour cell radiosensitization using constitutive (CMV) and radiation inducible (WAF1) promoters to drive the iNOS gene: a novel suicide gene therapy

Pulmonary cytokine responses associated with PEI-DNA aerosol gene therapy